Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added primary peritoneal carcinoma to the conditions and included the Genetic and Rare Diseases Information Center under resources. Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T11:35:40.000Z thumbnail image
  2. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is displayed in place of v3.4.0, a minor version label update that does not affect study content or available actions for users.
    Difference
    0.1%
    Check dated 2026-02-05T12:54:01.000Z thumbnail image
  3. Check
    10 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated the QC status line to 'Last Update Submitted that Met QC Criteria.' Minor capitalization changes for 'No FEAR Act Data' and a site revision label 'Revision: v3.4.0' were also applied.
    Difference
    0.2%
    Check dated 2026-01-29T06:22:20.000Z thumbnail image
  4. Check
    17 days ago
    Change Detected
    Summary
    The page now displays a 'Last Update Posted' timestamp field, and the previous 'Last Update Posted (Estimated)' label has been removed. This is a UI/metadata update rather than a change to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T04:53:59.000Z thumbnail image
  5. Check
    24 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.3.3 to v3.3.4. No study details or content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:53:46.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Introduced a new Locations section listing study sites in Florida, Pennsylvania, Tennessee, Virginia, and Wisconsin. The footer will show Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-24T14:54:56.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.